Broncus Holding Corporation
Broncus Holding Corporation (BRNHF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
brnhf · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Devices · 5 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Broncus Holding CorporationYou BRNHF | $162M | N/A | — | — |
 Adocia S.A. ADOCY | $170M | N/A | — | -$0.81 |
 ACS Global, Inc. AMCY | $171M | N/A | — | — |
 Anteris Technologies Ltd AMEUF | $120M | N/A | — | -$6.09 |
 Cell MedX Corp. CMXC | $126M | N/A | — | -$0.03 |
 China Medical & HealthCare Group Limited COLRF | $123M | 0.03x | — | $0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Broncus Holding Corporation (BRNHF) measures how much investors pay for each dollar of the company's trailing earnings. BRNHF's current PE ratio of N/A is calculated by dividing its stock price of $0.31 by its TTM earnings per share of —.
Frequently asked questions
BRNHF pe ratio · 6 questionsBRNHF's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.31 and TTM EPS of —. Data sourced from Financial Modeling Prep via BRNHF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Broncus Holding Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10